Literature DB >> 3762406

Procedures for in vitro DNA mutagenesis of human leukocyte interferon sequences.

T M DeChiara, F Erlitz, S J Tarnowski.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3762406     DOI: 10.1016/0076-6879(86)19060-4

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


× No keyword cloud information.
  7 in total

1.  Retroviral integrase domains: DNA binding and the recognition of LTR sequences.

Authors:  E Khan; J P Mack; R A Katz; J Kulkosky; A M Skalka
Journal:  Nucleic Acids Res       Date:  1991-02-25       Impact factor: 16.971

2.  A simple method for site-directed mutagenesis with double-stranded plasmid DNA.

Authors:  D Lai; X Zhu; S Pestka
Journal:  Mol Biotechnol       Date:  1998-06       Impact factor: 2.695

3.  The regulated production of mu m and mu s mRNA is dependent on the relative efficiencies of mu s poly(A) site usage and the c mu 4-to-M1 splice.

Authors:  M L Peterson; R P Perry
Journal:  Mol Cell Biol       Date:  1989-02       Impact factor: 4.272

4.  Avian sarcoma-leukosis virus pol-endo proteins expressed independently in mammalian cells accumulate in the nucleus but can be directed to other cellular compartments.

Authors:  C Morris-Vasios; J P Kochan; A M Skalka
Journal:  J Virol       Date:  1988-01       Impact factor: 5.103

5.  A C-terminal domain in the avian sarcoma-leukosis virus pol gene product is not essential for viral replication.

Authors:  R A Katz; A M Skalka
Journal:  J Virol       Date:  1988-02       Impact factor: 5.103

6.  A simple and efficient method for site-directed mutagenesis with double-stranded plasmid DNA.

Authors:  D Lai; X Zhu; S Pestka
Journal:  Nucleic Acids Res       Date:  1993-08-25       Impact factor: 16.971

7.  A novel upstream element compensates for an ineffectual octamer motif in an immunoglobulin V kappa promoter.

Authors:  M L Atchison; V Delmas; R P Perry
Journal:  EMBO J       Date:  1990-10       Impact factor: 11.598

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.